Zobrazeno 1 - 10
of 102
pro vyhledávání: '"F Tricta"'
Autor:
MPA Verissimo, MS Elalfy, M Hamdy, A El-Beshlawy, F Ebeid, J Kanter, S Williams, D Lee, F Tricta, JL Kwiatkowski
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S23-S24 (2021)
Objectives: Assess the safety and efficacy of deferiprone (DFP) in chronically transfused, iron-overloaded patients with sickle cell disease (SCD) or other anemias. Methods: FIRST was a multicenter, 1-year, noninferiority trial of DFP vs deferoxamine
Externí odkaz:
https://doaj.org/article/a031bbe1c98a4b1fa51a8b9c7bd6aa6b
Autor:
B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Publikováno v:
HemaSphere, Vol 6, Pp 10-11 (2022)
Externí odkaz:
https://doaj.org/article/1b0cabea9d4d4e28939e5a874c13ea38
Autor:
M Elalfy, A El-Beshlawy, A Adly, F Ebeid, C Fradette, D Lee, N Temin, F Tricta, A Rozova, M Hamdy
Publikováno v:
HemaSphere, Vol 6, Pp 12-13 (2022)
Externí odkaz:
https://doaj.org/article/a1cbff48e11f493e973e0098dcde6869
Autor:
B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Publikováno v:
HemaSphere, Vol 6, Pp 8-8 (2022)
Externí odkaz:
https://doaj.org/article/f45770dcbdce4df298098f6e53a3b483
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Hamdy, A El-Beshlawy, FS Ebeid, JL Kwiatkowski, J Kanter, B Inusa, S Williams, M Verissimo, D Lee, NT Temin, C Fradette, F Tricta, MS Elalfy
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S338-S339
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d252cb02199c2f4a135ffd0f026803d
https://doi.org/10.1016/j.htct.2022.09.573
https://doi.org/10.1016/j.htct.2022.09.573
Publikováno v:
HemaSphere. 6:1392-1393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6a32df85a24c2a711eb8e417e11d38
https://doi.org/10.1097/01.hs9.0000848900.86224.01
https://doi.org/10.1097/01.hs9.0000848900.86224.01
Publikováno v:
HemaSphere. 6:2101-2102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9b216a43bfdb94ab4eb48ad5b28c201
https://doi.org/10.1097/01.hs9.0000851752.44738.4e
https://doi.org/10.1097/01.hs9.0000851752.44738.4e
Publikováno v:
HemaSphere. 6:1439-1440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::197440c45faf1318788d90faf83a384c
https://doi.org/10.1097/01.hs9.0000849088.46934.99
https://doi.org/10.1097/01.hs9.0000849088.46934.99
Autor:
Amal El-Beshlawy, Janet L. Kwiatkowski, Mpa Verissimo, Elalfy, Julie Kanter, Mona Hamdy, Suzan Williams, F Tricta, D Lee, Fatma S E Ebeid
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss, Pp S23-S24 (2021)
Objectives: Assess the safety and efficacy of deferiprone (DFP) in chronically transfused, iron-overloaded patients with sickle cell disease (SCD) or other anemias. Methods: FIRST was a multicenter, 1-year, noninferiority trial of DFP vs deferoxamine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44bea2a7bc96ed43454a192b54566665
https://doi.org/10.1016/j.htct.2021.10.040
https://doi.org/10.1016/j.htct.2021.10.040